Resolving Inflammatory Storm in COVID-19 Patients by Omega-3 Polyunsaturated Fatty Acids -

NCT04647604 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Omegaven®
DRUG: Sodium chloride

Sponsor

Karolinska University Hospital